These new medications, like copyright and Semaglutide, represent a important class of drugs called GLP-1 receptor activators. This class of medications work by glp1 meds enhancing the body's intrinsic ability to release GLP-1, a chemical that helps manage sugar levels and food intake. Originally, designed for managing type 2 high blood sugar, they